Technology | July 31, 2012

Siemens’ Magnetom Spectra 3.0T MRI System Receives FDA Clearance

Cost-optimized system with Tim 4G and Dot technologies facilitates access to premium 3T imaging

July 31, 2012 — Siemens Healthcare announced that the Magnetom Spectra 3.0T magnetic resonance imaging (MRI) system has received clearance from the U.S. Food and Drug Administration (FDA). The latest addition to Siemens’ portfolio of MRI solutions, the Magnetom Spectra system offers premium imaging at a reduced total cost of ownership when compared to other scanners in the product range. Designed for easy and efficient operation, the cost-optimized Magnetom Spectra system is innovative and competitive, two primary goals of Siemens Healthcare’s Agenda 2013 two-year global initiative.

“Siemens Healthcare is proud to offer the Magnetom Spectra MRI system, which opens the door to 3.0T imaging technology for a wider range of healthcare facilities,” said Ioannis Panagiotelis, Ph.D., vice president of MR, Siemens Healthcare. “The Magnetom Spectra delivers crisp, high-resolution images that provide the key to a new level of usability and diagnostic confidence for physicians.”

The Magnetom Spectra system employs Tim (Total imaging matrix) 4G technology, Siemens’ latest coil generation. This modern array structure allows for high spatial and temporal resolution; previously, images of similar quality could only be produced by 3.0T systems that require a higher investment.

The system also consumes less energy than other 3.0T scanners. The magnet-cooling helium is contained in a closed loop, preventing the gas from escaping and reducing the need for costly refills. In addition, various system components help technologists simplify the MRI examination process. For example, the cableless direct-connect coils allow for simple and quick setup, with up to 120 coil elements capable of being combined in a flexible manner. For this reason, even scans with large anatomical coverage up to whole-body scans (205 cm, or 80.71 inches) can be performed in one examination without patient or coil repositioning.

The Magnetom Spectra system can be used for a broad spectrum of applications, from diagnosing damaged ankle cartilage to conducting dynamic abdominal examinations and performing functional brain imaging. To reduce exam complexity, the system is equipped with Siemens' MRI workflow solution Dot (Day optimizing throughput), which enables easy, fast selection of the best scan strategy based on the patient's condition and the clinical indication. Users benefit from step-by-step guidance throughout the examination, receiving decision-making assistance at critical junctures to support consistent, reproducible scanning across patients.

For more information:

Related Content

Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab| October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
CMS, Overall Hospital Quality Star Rating, national distribution, quailty of care
News | Business| July 26, 2016
July 25, 2016 — The Centers for Medicare and Medicaid Services (CMS) announced that it expects to launch its new Over
Siemens Healthineers, Enterprise Services, ES, U.S. launch
Technology | Cardiac Imaging| July 19, 2016
July 19, 2016 — Siemens Healthineers recently introduced an expanded Services portfolio, known as Enterprise Services
Sponsored Content | Webinar | July 19, 2016
This webinar will explain the prevalence of MRI motion artifacts, outline the related financial and time burdens asso
gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns
News | Magnetic Resonance Imaging (MRI)| July 12, 2016
The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing the U.S. Food...
MRI scanners, helium gas field discovery, Africa, future supply
News | Magnetic Resonance Imaging (MRI)| July 01, 2016
July 1, 2016 — Helium is essential for many modern technologies, including...
Vital Images, Vitrea 7 advanced visualization software, SCCT 2016
Technology | Advanced Visualization| June 30, 2016
Vital Images Inc. recently launched version 7 of its Vitrea advanced visualization software. This application-based...
DEFUSE-2 study, MRI, brain bleeding risk, post-stroke treatment, NIH

This image combines pre- and post-treatment scans from the same patient. Analysis of the two scans revealed that the area and size of post-treatment bleeding corresponded to blood-brain barrier disruption (shown in green, yellow and red) prior to therapy. Image courtesy of Richard Leigh, NINDS.

News | Stroke| June 29, 2016
In a study of stroke patients, investigators confirmed through magnetic resonance imaging (MRI) brain scans an...
BHF, Reflections of Research image competition, U.K., 4-D MRI, heart blood flow

This image shows blood flow within the main pumping chambers – the ventricles – on both sides of the heart and the vessels leaving the heart. The blue flow is blood that needs oxygen and is travelling to the lungs. The red flow is blood that has been through the lungs and received oxygen. Victoria Stoll of the University of Oxford is using this type of imaging to look at the blood flow within the hearts of people with heart failure, whose hearts are not pumping effectively.

News | Cardiac Imaging| June 24, 2016
The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition,...
Overlay Init